Home

Notable Labs, Ltd. - Ordinary Shares (NTBL)

0.2479
0.00 (0.00%)

Notable Labs, Ltd. is a biotechnology company focused on developing innovative therapies for cancer treatment

The company employs its proprietary drug discovery platform to evaluate patient-specific cancer cells in order to identify effective treatment options based on individual responses. By personalizing medicine, Notable Labs aims to optimize therapeutic outcomes for cancer patients, enhancing the precision and efficacy of treatments while minimizing unnecessary side effects. Their approach emphasizes collaboration with healthcare providers and researchers to advance personalized cancer care.

SummaryNewsPress ReleasesChartHistoricalFAQ